Previous work has demonstrated that TNF-α induces the anemia in IBD patients by weakening absorption of iron [21, 22], while anti-TNF-α therapy improves anemia in CD patients and is associated with the decreased levels of serum hepcidin [23, 24]. This evidence concerns the gene TNF and anemia (phenotype).